Common Contracts

SETTLEMENT AGREEMENT

Settlement Agreement • September 29th, 2022 • Pennsylvania

• Contract Type
  Settlement Agreement
• Filed
  September 29th, 2022
• Jurisdiction
  Pennsylvania

THIS SETTLEMENT AGREEMENT (the “Settlement Agreement”) is made and entered into on April 17, 2015, by and between Defendants Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., and Barr Pharmaceuticals, Inc. (collectively, the “Cephalon Defendants”), and Direct Purchaser Plaintiffs’ Lead Counsel acting pursuant to the Court’s Order, dated August 18, 2009 (Doc. No. 196), on behalf of Plaintiffs King Drug Co. of Florence, Inc. (“King Drug”), Rochester Drug Co-Operative, Inc. (“RDC”), Burlington Drug Company Inc. (“Burlington”), J.M. Smith Corp. d/b/a Smith Drug Co. (“Smith Drug”), Meijer, Inc. and Meijer Distribution, Inc. (“Meijer”), Stephen L. LaFrance Pharmacy d/b/a SAJ Distributors, Inc. and Stephen L. LaFrance Holdings, Inc. (“SAJ” and together with King Drug, RDC, Burlington, Smith Drug, and Meijer, the “King Drug Direct Purchaser Class Plaintiffs,” “named Plaintiffs,” or “Plaintiffs”), and on behalf of the Direct Purchaser Class (as defined in para